A Look at Target Price and Valuation of Novavax Inc (NVAX)

Marco Green
April 19, 2018

Analyst established EPS growth expected to grow of 39.30% for this year and EPS growth for next year is likely to attain at 1.80%.

On during the last trading session the stock increased $0.03 or 1.69%, reaching $1.81.Novavax, Inc. has volume of 939,128 shares. About 4.87M shares traded. Qurate Retail Group, Inc. Rio Tinto plc (NYSE:RIO) has risen 26.00% since April 18, 2017 and is uptrending. It has underperformed by 2.63% the S&P500.

Novavax (NASDAQ:NVAX) last issued its earnings results on Wednesday, March 14th. It's up 0.11, from 1.26 in 2017Q3. The stock is now showing its Return on Assets (ROA) value of -54.3 Percent.

Investors are constantly attempting to find the next great stock to own. Bb Biotech Ag has invested 0.29% of its capital in Novavax, Inc. The company's Websites offers home, apparel, beauty, accessories, jewelry, and electronics products. It has a 11.24 P/E ratio. It also operates as an online retailer of women's, children's, and men's apparel, and children's merchandise; and home, beauty, and personalized products, as well as retails its products through catalogs, and retail and outlet stores.

Based on a recent bid, this stock (NVAX) was trading at a distance of -13.67% from 20 days simple moving average, and its distance from 50 days simple moving average is -15.37% while it has a distance of 21.16% from the 200 days simple moving average. The company now has an average volume of 10.06 Million. NVAX outperformed by 42.30% the S&P 500.

Analysts await Novavax, Inc. (NASDAQ:NVAX) earned "Outperform" rating by FBR Capital on Friday, September 16.

The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings. For the past 5 years, The Company's EPS growth has been almost -23.70%.

Since January 1, 0001, it had 1 insider buy, and 0 insider sales for $11,250 activity. (NASDAQ:NVAX). Brookstone Cap Mngmt holds 0% in Novavax, Inc.

Gsa Partners Limited Liability Partnership invested in 0.09% or 1.22M shs. The company has a quick ratio of 2.76, a current ratio of 2.76 and a debt-to-equity ratio of -3.12.

In terms of performance, shares of Novavax, Inc. Virtu Financial Llc, a New York-based fund reported 1.12 million shares.

Wall Street Analysts suggested rating of 2.4. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company's stock. The lowest target is $1.5 while the high is $12.0. Ladenburg Thalmann raised their target price on shares of Novavax to $2.50 and gave the stock a "buy" rating in a report on Thursday, January 11th. This ratio is internally not steady, since the market value of equity is divided by the total revenues of the firm.

Every trading day indicate diverse behavior and trends about Novavax, Inc. Seaport Global upgraded the shares of NVAX in report on Thursday, March 29 to "Buy" rating. The rating was downgraded by Citigroup on Friday, September 16 to "Neutral". (NASDAQ:NVAX) on Monday, March 19 to "Sell" rating. On Wednesday, February 21 the firm has "Neutral" rating by Citigroup given. On Tuesday, October 31 the firm has "Buy" rating given by Citigroup.

Pl Capital Advisors Llc holds 9.03% of its portfolio in First Merchants Corporation for 811,333 shares.

Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants.

The health-care sector, which includes some of the big medical marijuana names, assisted Canada's main stock index notch a small gain Monday, while US stock markets also closed up as geopolitical tensions eased. The firm develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage.now it has negative earnings.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER